The Egyptian Drug Authority (EDA) announces a Public Consultation regarding the Guidelines for Nitrosamine Impurities in Drug Substances and Pharmaceutical Drug Products.

We are honored to receive the completed forms for the public consultation (Public Consultation Form) via the following email: dc.tech@edaegypt.gov.eg. The submissions should be in Soft Word Form.

To review the draft regulatory guideline, please click on the link: 

Click to view the list

Please note that the deadline for receiving feedback and suggestions is Tuesday, November 18, 2025.